Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Affects of a Bifidobacterium Longum Combination on Health Outcomes Associated With Short-Term Overseas Travel

NCT07705659 is registered in ClinicalTrials.gov with DiproBio (Shanghai) Co., Ltd. as lead sponsor.

NCT NCT07705659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07705659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Affects of a Bifidobacterium Longum Combination on Health Outcomes Associated With Short-Term Overseas Travel
Lead sponsor
DiproBio (Shanghai) Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 30, 2026
Completion date
March 31, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

changes in gut microbiota, gut metabolites, respiratory symptoms, and well-being index